SCHEMBL6539239

SCHEMBL6539239

CC(C)n1nc(-c2ccc(Cl)nc2-c2ccccc2)ccc1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
ADORA2A P29274 2/20 0.39
TP53 P04637 2/20 0.38
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36
PDE1C Q14123 1/20 0.36
LMNA P02545 1/20 0.35
P2RY6 Q15077 1/20 0.34
RECQL P46063 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
BMPR1B O00238 1/20 0.34
BMPR1A P36894 1/20 0.34
TGFBR1 P36897 1/20 0.34
ACVRL1 P37023 1/20 0.34
ACVR1 Q04771 1/20 0.34
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539191 0.88 TP53 (0.38) POLBADORA2ATP53PDE1APDE1B
SCHEMBL6538914 0.82 TP53 (0.38) POLBADORA2ATP53PDE1APDE1B
SCHEMBL6538926 0.81 POLB (0.39) POLBADORA2ATP53PDE1APDE1B
SCHEMBL6538919 0.81 POLB (0.39) POLBADORA2ATP53PDE1APDE1B
SCHEMBL6538828 0.80 PTGS1 (0.43) POLBTP53PDE1APDE1BPDE1C
SCHEMBL6539012 0.79 POLB (0.42) POLBADORA2ATP53PDE1APDE1B
SCHEMBL6539021 0.79 TP53 (0.45) POLBADORA2ATP53LMNAKDM4E
SCHEMBL6537897 0.78 NPSR1 (0.47) POLBADORA2APDE1APDE1BPDE1C
SCHEMBL6539007 0.78 PDE9A (0.39) ADORA2ATP53LMNAKDM4EALDH1A1
SCHEMBL6538477 0.78 ADORA2A (0.38) POLBADORA2ATP53PDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067955-A1 Pyridazinone compound and pharmaceutical use thereof ADORA1, ADORA2A, P2RX5 POLB 2406/4885ADORA2A 2/4885TP53 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.